Skip to Content

Case Overview

60 Days Left to Seek Lead Plaintiff
Lead Plaintiff Deadline:Lead Plaintiff Deadline:01/08/2027
Status:Status:Investigating
Company Name:Company Name:CVRx, Inc.
Court:Court:District of Minnesota
Case Number:Case Number:0:26cv04746
Class Period:Class Period:07/25/2023 - 08/06/2026
Ticker:Ticker:CVRX
Related Attorneys:Lead Attorneys:Thomas W. Elrod
Related Practices:Related Practices:Securities
The lawsuit alleges that CVRx made materially false and/or misleading statements and failed to disclose that: (i) to induce sales growth, CVRx and/or its employees were engaged in illegal and unsustainable sales practices, including improperly marketing Barostim, offering or paying kickbacks, and providing false information to government health insurance programs in violation of the False Claims Act (“FCA”) and Anti-Kickback Statute (“AKS”); (ii) CVRx’s revenues were in part the product of such unlawful conduct and thus unsustainable; and (iii) the illegal sales and marketing activities increased the risk of criminal and civil liability.

On August 6, 2026, CVRx filed with the SEC a Quarterly Report on Form 10-Q, disclosing that, on May 14, 2026, the Company “received a civil investigative demand (‘CID’) from the U.S Department of Justice in connection with an investigation under the False Claims Act.” CVRx stated, “The CID requested information and documents regarding an investigation into whether we caused the submission of false claims to government health insurance programs by improperly marketing our device, offering or paying kickbacks to healthcare providers or providing false information to government health insurance programs.” Additionally, the Company lowered its revenue guidance, citing challenges with sales force productivity. On this news, the price of CVRx shares declined by $3.55 per share, or approximately 60%, from $5.94 per share on August 6, 2026 to close at $2.39 on August 7, 2026.
 

Contact Us About This Case

You may share a link to this page on any of the sites listed below or send link via email: